Nucor (NUE) Competitors

In the previous week, Nucor had 25 more articles in the media than ATI. MarketBeat recorded 34 mentions for Nucor and 9 mentions for ATI. Nucor's average media sentiment score of 1.29 beat ATI's score of 1.19 indicating that Nucor is being referred to more favorably in the media.

76.5% of Nucor shares are held by institutional investors. 0.6% of Nucor shares are held by company insiders. Comparatively, 1.0% of ATI shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

ATI has a net margin of 9.26% compared to Nucor's net margin of 6.82%. ATI's return on equity of 26.44% beat Nucor's return on equity.

Nucor has a beta of 1.88, indicating that its stock price is 88% more volatile than the broader market. Comparatively, ATI has a beta of 0.96, indicating that its stock price is 4% less volatile than the broader market.

Nucor pays an annual dividend of $2.24 per share and has a dividend yield of 0.9%. ATI pays an annual dividend of $0.32 per share and has a dividend yield of 0.2%. Nucor pays out 22.2% of its earnings in the form of a dividend. ATI pays out 10.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Nucor has raised its dividend for 52 consecutive years. Nucor is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Nucor has higher revenue and earnings than ATI. Nucor is trading at a lower price-to-earnings ratio than ATI, indicating that it is currently the more affordable of the two stocks.

Nucor currently has a consensus target price of $247.50, indicating a potential downside of 2.77%. ATI has a consensus target price of $164.38, indicating a potential downside of 7.65%. Given Nucor's higher probable upside, research analysts clearly believe Nucor is more favorable than ATI.

76.5% of Nucor shares are held by institutional investors. Comparatively, 93.2% of Cabot shares are held by institutional investors. 0.6% of Nucor shares are held by insiders. Comparatively, 3.1% of Cabot shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Nucor currently has a consensus target price of $247.50, suggesting a potential downside of 2.77%. Cabot has a consensus target price of $80.25, suggesting a potential downside of 8.03%. Given Nucor's stronger consensus rating and higher possible upside, analysts plainly believe Nucor is more favorable than Cabot.

In the previous week, Nucor had 32 more articles in the media than Cabot. MarketBeat recorded 34 mentions for Nucor and 2 mentions for Cabot. Nucor's average media sentiment score of 1.29 beat Cabot's score of 0.77 indicating that Nucor is being referred to more favorably in the media.

Nucor has higher revenue and earnings than Cabot. Cabot is trading at a lower price-to-earnings ratio than Nucor, indicating that it is currently the more affordable of the two stocks.

Nucor has a beta of 1.88, meaning that its share price is 88% more volatile than the broader market. Comparatively, Cabot has a beta of 0.82, meaning that its share price is 18% less volatile than the broader market.

Cabot has a net margin of 7.97% compared to Nucor's net margin of 6.82%. Cabot's return on equity of 21.33% beat Nucor's return on equity.

Nucor pays an annual dividend of $2.24 per share and has a dividend yield of 0.9%. Cabot pays an annual dividend of $1.89 per share and has a dividend yield of 2.2%. Nucor pays out 22.2% of its earnings in the form of a dividend. Cabot pays out 35.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Nucor has raised its dividend for 52 consecutive years and Cabot has raised its dividend for 14 consecutive years.

Nucor pays an annual dividend of $2.24 per share and has a dividend yield of 0.9%. Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 1.5%. Nucor pays out 22.2% of its earnings in the form of a dividend. Chemours pays out -13.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Nucor has raised its dividend for 52 consecutive years. Chemours is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, Nucor had 34 more articles in the media than Chemours. MarketBeat recorded 34 mentions for Nucor and 0 mentions for Chemours. Nucor's average media sentiment score of 1.29 beat Chemours' score of 0.00 indicating that Nucor is being referred to more favorably in the media.

Nucor has a beta of 1.88, indicating that its stock price is 88% more volatile than the broader market. Comparatively, Chemours has a beta of 1.47, indicating that its stock price is 47% more volatile than the broader market.

76.5% of Nucor shares are owned by institutional investors. Comparatively, 76.3% of Chemours shares are owned by institutional investors. 0.6% of Nucor shares are owned by company insiders. Comparatively, 0.9% of Chemours shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Nucor presently has a consensus target price of $247.50, indicating a potential downside of 2.77%. Chemours has a consensus target price of $24.60, indicating a potential upside of 5.62%. Given Chemours' higher possible upside, analysts clearly believe Chemours is more favorable than Nucor.

Nucor has higher revenue and earnings than Chemours. Chemours is trading at a lower price-to-earnings ratio than Nucor, indicating that it is currently the more affordable of the two stocks.

Nucor has a net margin of 6.82% compared to Chemours' net margin of -6.82%. Chemours' return on equity of 52.49% beat Nucor's return on equity.

Nucor pays an annual dividend of $2.24 per share and has a dividend yield of 0.9%. Celanese pays an annual dividend of $0.12 per share and has a dividend yield of 0.2%. Nucor pays out 22.2% of its earnings in the form of a dividend. Celanese pays out -1.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Nucor has raised its dividend for 52 consecutive years. Nucor is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

In the previous week, Nucor had 22 more articles in the media than Celanese. MarketBeat recorded 34 mentions for Nucor and 12 mentions for Celanese. Nucor's average media sentiment score of 1.29 beat Celanese's score of 0.36 indicating that Nucor is being referred to more favorably in the media.

76.5% of Nucor shares are owned by institutional investors. Comparatively, 98.9% of Celanese shares are owned by institutional investors. 0.6% of Nucor shares are owned by company insiders. Comparatively, 0.3% of Celanese shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Nucor currently has a consensus price target of $247.50, suggesting a potential downside of 2.77%. Celanese has a consensus price target of $67.81, suggesting a potential upside of 21.75%. Given Celanese's higher possible upside, analysts clearly believe Celanese is more favorable than Nucor.

Nucor has a net margin of 6.82% compared to Celanese's net margin of -11.54%. Nucor's return on equity of 10.68% beat Celanese's return on equity.

Nucor has higher revenue and earnings than Celanese. Celanese is trading at a lower price-to-earnings ratio than Nucor, indicating that it is currently the more affordable of the two stocks.

Nucor has a beta of 1.88, indicating that its share price is 88% more volatile than the broader market. Comparatively, Celanese has a beta of 0.74, indicating that its share price is 26% less volatile than the broader market.